FLT3 inhibitors in acute myeloid leukemia

Overview of attention for article published in Journal of Hematology & Oncology, December 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news: 3 news outlets

patent: 3 patents

Citations

dimensions_citation: 124 Dimensions

Readers on

mendeley: 170 Mendeley

Summary News Patents Dimensions citations

So far, Altmetric has seen 3 news stories from 3 outlets.

GNF-7, a novel FLT3 inhibitor, overcomes drug resistance for the treatment of FLT3‑ITD acute myeloid leukemia

Cancer Cell International, 30 Nov 2023

Abstract Background Acute myeloid leukemia (AML) with FMS-like tyrosine kinase 3 internal tandem duplication (FLT3-ITD…

Gilteritinib more effective than salvage chemotherapy for FLT3-mutated acute myeloid leukemia | 2 Minute Medicine

2 Minute Medicine , 15 Nov 2019

1. In this phase 3 trial, patients with relapsed or refractory acute myeloid leukemia who received gilteritinib had a longer…

FLT3 inhibitors in acute myeloid leukemia

Medical Health News, 06 Dec 2018

Acute myeloid leukemia (AML) remains a highly resistant disease to conventional chemotherapy, with a median survival of only 4…